Found 54 matching trials
Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) PHASE2 Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Show More Location
University Hospital Cologne
Learn More & Join Trial
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) PHASE2 The current national acute lymphoblastic leukaemia (ALL) trial in adults in...
Show More Status
Active Not Recruiting
Location
Heart of England Nhs Foundation Trust
Learn More & Join Trial
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases PHASE2 This study proposes the use of a reduced intensity chemotherapy/radiation t...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO NA Patients have severe beta-thalassemia or one of the thalassemia variants. T...
Show More Location
Texas Children's Hospital
Learn More & Join Trial
Safety and Efficacy of Campath in Nonmyeloablative Transplantation NA Objective of the low-dose transplant regimen must produce the following eff...
Show More Location
U.T.M.D. Anderson Cancer Center
Learn More & Join Trial
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy, such as fludarabine, cyclophosphamid...
Show More Location
Allgemeines Krankenhaus - Universitatskliniken
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies NA This is a standard of care treatment guideline for allogeneic hematopoetic ...
Show More Status
Active Not Recruiting
Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia PHASE2 The primary objective of this study was to evaluate the safety and efficacy...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP PHASE3 RATIONALE: Drugs used in chemotherapy, such as fludarabine and cyclophospha...
Show More Location
Centre Henri Becquerel
Learn More & Join Trial
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders PHASE1 This study is designed to estimate the efficacy and toxicity of familial HL...
Show More Location
Yale School of Medicine
Learn More & Join Trial